Stay updated on Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial

Sign up to get notified when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a new Publications section featuring a specific PubMed-listed study on cenobamate efficacy in focal seizure subtypes; no deletions were made. This expands authoritative sources on the page.
    Difference
    4%
    Check dated 2025-10-21T01:40:19.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now includes a government-funding notice and the new version tag v3.2.0, replacing the old v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T16:09:18.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added new version tag v3.1.0 and removed multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs, etc.), indicating a content consolidation or reorganization with focus shift away from those safety sections.
    Difference
    0.4%
    Check dated 2025-09-29T10:10:59.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive changes to core content, pricing, stock availability, or time-slot information.
    Difference
    0.2%
    Check dated 2025-09-15T01:08:08.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T23:01:04.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated to include specific drug information for Cenobamate and details regarding drug safety, counterfeit drugs, and substandard drugs, while also changing the revision number from v2.16.12 to v3.0.0. Additionally, the facility name and location have been specified as Seoul, South Korea.
    Difference
    2%
    Check dated 2025-08-31T19:58:43.000Z thumbnail image

Stay in the know with updates to Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy and Safety of Cenobamate Adjunctive Therapy in POS Clinical Trial page.